Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

PEG-hemoglobin undergoes trial

June 28, 1996

Potential photodynamic therapy described

June 28, 1996

Pharmacyclic's Gd-Tex enhances radiation therapy

June 28, 1996

Pan-agonist retinoid described by Ligand

June 28, 1996

Antineoplastic/antifungal agent revealed

June 28, 1996

MT-332: Pharma Mar's novel cytotoxic metabolite

June 28, 1996

Antitumor epidioxymanadic acid described by Pharma Mar

June 28, 1996

Marimastat enters U.S. and U.K. phase III trial

June 28, 1996

Therapeutic melanoma vaccine in phase I

June 28, 1996

Eulexin is FDA-approved for new indication

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...